User profiles for J. L. Derks

Jules Derks

Maastricht University Medical Centre
Verified email at maastrichtuniversity.nl
Cited by 1113

[HTML][HTML] New insights into the molecular characteristics of pulmonary carcinoids and large cell neuroendocrine carcinomas, and the impact on their clinical …

JL Derks, N Leblay, S Lantuejoul… - Journal of Thoracic …, 2018 - Elsevier
Carcinoids and large cell neuroendocrine carcinomas (LCNECs) are rare neuroendocrine
lung tumors. Here we provide an overview of the most updated data on the molecular …

[HTML][HTML] Clinical-pathologic challenges in the classification of pulmonary neuroendocrine neoplasms and targets on the horizon for future clinical practice

JL Derks, N Rijnsburger, BCM Hermans… - Journal of Thoracic …, 2021 - Elsevier
Diagnosing a pulmonary neuroendocrine neoplasm (NEN) may be difficult, challenging
clinical decision making. In this review key clinical and pathological issues and informative …

Molecular subtypes of pulmonary large-cell neuroendocrine carcinoma predict chemotherapy treatment outcome

JL Derks, N Leblay, E Thunnissen, RJ Van Suylen… - Clinical Cancer …, 2018 - AACR
Purpose: Previous genomic studies have identified two mutually exclusive molecular subtypes
of large-cell neuroendocrine carcinoma (LCNEC): the RB1 mutated (mostly comutated …

Clinical features of large cell neuroendocrine carcinoma: a population-based overview

JL Derks, LE Hendriks, WA Buikhuisen… - European …, 2016 - Eur Respiratory Soc
Pulmonary large cell neuroendocrine carcinoma (LCNEC) is an orphan disease and few
data are available on its clinical characteristics. Therefore, we analysed LCNEC registered in …

Pulmonary neuroendocrine neoplasms with well differentiated morphology and high proliferative activity: illustrated by a case series and review of the literature

BCM Hermans, JL Derks, L Moonen, CHJ Habraken… - Lung Cancer, 2020 - Elsevier
Objectives Pulmonary neuroendocrine neoplasms (NENs) are subdivided in carcinoids and
neuroendocrine carcinomas (small cell lung carcinoma and large cell neuroendocrine …

Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?

JL Derks, RJ Van Suylen, E Thunnissen… - European …, 2017 - Eur Respiratory Soc
Derks and R. van Sulyen prior to the central review meetings. The assessors evaluated …
Derks). LCNEC was established when at least two pathologists agreed on the diagnosis, …

[HTML][HTML] Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer

C Kuijpers, LEL Hendriks, JL Derks, AMC Dingemans… - Lung Cancer, 2018 - Elsevier
Objectives Biological predisposition for specific metastatic organs might differ between
molecular subgroups of lung cancer. We aimed to assess the association between molecular …

[HTML][HTML] Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: results from a …

LE Hendriks, JL Derks, PE Postmus… - European journal of …, 2015 - Elsevier
Purpose To analyse the prognostic impact on overall survival (OS) of single versus multiple
organ metastases, organ affected, and local disease status in a population based stage IV …

DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile

BCM Hermans, JL Derks, E Thunnissen, RJ van Suylen… - Lung Cancer, 2019 - Elsevier
… Author links open overlay panel BCM Hermans a , JL Derks a , E. Thunnissen b , RJ van
Suylen c , MA den Bakker d e , HJM Groen f , EF Smit g , RA Damhuis h , EC van den Broek i , …

Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens?

JL Derks, AMC Dingemans, RJ van Suylen… - …, 2019 - Wiley Online Library
Aims Pulmonary large cell neuroendocrine carcinoma ( LCNEC ) is underdiagnosed on biopsy
specimens. We evaluated if routine neuroendocrine immunohistochemical ( IHC ) stains …